On the other hand, we tested the CRP/Alb ratio in predicting the outcome of VC because this novel marker has gained significant attention recently for its ability to detect malnutrition and systemic inflammation in ovarian [112] and cervical cancers [113]. This evidence concerns the gene ALB and cervical cancer.